Rituximab and CHOP every 14-days (R-CHOP 14) in younger patients with advanced diffuse large-B-cell non-Hodgkin's lymphoma (DLBCL) - An update of efficacy and safety.

被引：0
|
作者：
Ranze, OP [1 ]
Arland, M [1 ]
Hoffkes, HG [1 ]
机构：
[1] Klinikum Fulda, Ctr Canc, Fulda, Germany
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4859
引用
收藏
页码：284B / 284B
页数：1
相关论文
共 50 条
  • [1] R-CHOP 14 IN THE TREATMENT OF DIFFUSE LARGE-B-CELL LYMPHOMA: RETROSPECTIVE STUDY OF EFFICACY AND TOXICITY
    Couto, E.
    Almeida, M.
    Portela, C.
    Nabico, R.
    Marques, H.
    ANNALS OF ONCOLOGY, 2010, 21 : 359 - 359
  • [2] A phase III trial comparing R-CHOP 14 and R-CHOP 21 for the treatment of patients with newly diagnosed diffuse large B-cell non-Hodgkin's lymphoma
    Cunningham, D.
    Smith, P.
    Mouncey, P.
    Qian, W.
    Pocock, C.
    Ardeshna, K. M.
    Radford, J.
    Davies, J.
    McMillan, A.
    Linch, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] R-CHOP-14 in patients with diffuse large-B-cell lymphoma (DLBCL) younger than 70 years:: A multicentric and prospective study.
    Rueda, A.
    Sabin, P.
    Rifa, J.
    Llanos, M.
    Gomez-Codina, J.
    Lobo, F.
    Garcia-Arroyo, R.
    Herrero, J.
    Provencio, M.
    Jara, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 444S - 444S
  • [4] CHOP every 14 days in naive patients with diffuse B-large cell lymphoma.
    Rubio-Martinez, Araceli
    Palomera, Luis
    Gonzalez, Nicolas
    Domingo, Jose A.
    Arguinano, Carlos
    Puente, Fernando
    Perella, Matilde
    Angos, Jose A.
    Sancho, Ignacio
    Herrera, Pilar
    Recasens, Valle
    Giraldo, Pilar
    BLOOD, 2006, 108 (11) : 248B - 249B
  • [5] Prophylactic Use of Filgrastim on Days 7, 11 and 14 in Patients Receiving R-CHOP for Non-Hodgkin's Lymphoma
    El-Shakankery, Sherief
    Gabriel, Sumantha
    Groves, Emma
    BLOOD, 2019, 134
  • [6] Feasibility and preliminary efficacy of R-CHOP-14 in patients with diffuse large B-Cell lymphoma (DLBCL).
    Halaas, JL
    Moskowitz, CH
    Noy, A
    Portlock, C
    Horwitz, S
    Straus, D
    O'Connor, O
    Yahalom, J
    Zelenetz, AD
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 578S - 578S
  • [7] R-CHOP every 21 days for diffuse large B-cell lymphoma: still the standard of care?
    Westin, Jason
    Hagemeister, Fredrick
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2013, 2 (06) : 537 - 540
  • [8] Pegfilgrastim to support CHOP-R chemotherapy administered every 14 days in the patients (PTS) with aggressive B-CELL non-Hodgkin's Lymphoma (NHL)
    Capochiani, E.
    Cupini, S.
    Barbara, C.
    Fontana, A.
    Loupakis, F.
    Safina, V
    Vasile, E.
    Bursi, S.
    Coltelli, L.
    Landi, L.
    Baldi, G. G.
    Barletta, M. T.
    Giuntini, N.
    Lo Dico, M.
    Mazzoni, E.
    Masi, G.
    Falcone, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 213 - 213
  • [9] Pegfilgrastim to support CHOP-R chemotherapy administered every 14 days in the patients (Pts) with aggressive B-cell non-Hodgkin's lymphoma (NHL)
    Capochiani, E.
    Cupini, S.
    Loupakis, F.
    Vasile, E.
    Fontana, A.
    Barbara, C.
    Bursi, S.
    Landi, L.
    Coltelli, L.
    Safina, V.
    Barletta, M. T.
    Baldi, G. G.
    Giuntini, N.
    Lo Dico, M.
    Mazzoni, E.
    Masi, G.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2007, 18 : 67 - 67
  • [10] PROGNOSTIC SIGNIFICANCE OF SARCOPENIA IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH RITUXIMAB PLUS CHOP (R-CHOP)
    Go, S. I.
    Park, M. J.
    Kim, H. G.
    Kang, M. H.
    Lee, G. W.
    HAEMATOLOGICA, 2016, 101 : 686 - 687
12345